The monthly out-of-pocket cost of popular injections and upcoming pills could range from $50 to $350, depending on the dosage and insurance coverage.

The deal also means Medicare will start covering obesity drugs for some patients for the first time beginning next year.

The deals are among the most politically significant announcements to date in the Trump administration's efforts to rein in high U.S. drug costs.